We are live on ! Find out more
CIAS

CBIZ Investment Advisory Services Portfolio holdings

AUM $2.74B
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+14.19%
3 Year Est. Return
+39.3%
5 Year Est. Return
+29.82%
10 Year Est. Return
AUM
$2B
AUM Growth
+$78.1M
Cap. Flow
+$112M
Cap. Flow %
5.58%
Top 10 Hldgs %
94.01%
Holding
517
New
113
Increased
216
Reduced
53
Closed
40

Sector Composition

Rank Sector Weight
1 Industrials 1.96%
2 Technology 0.35%
3 Financials 0.14%
4 Healthcare 0.09%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRMD icon
251
iRadimed
IRMD
$1.14B
$14.3K ﹤0.01%
261
+73
+39% +$3.84K
PLTR icon
252
Palantir
PLTR
$422B
$14.3K ﹤0.01%
189
+30
+19% +$1.75K
HMC icon
253
Honda
HMC
$41.1B
$14.3K ﹤0.01%
500
EQIX icon
254
Equinix
EQIX
$102B
$14.3K ﹤0.01%
15
CFG icon
255
Citizens Financial Group
CFG
$30.8B
$13.9K ﹤0.01%
317
+53
+20% +$2.34K
NBIX icon
256
Neurocrine Biosciences
NBIX
$16.5B
$13.7K ﹤0.01%
+100
New +$12.4K
UPS icon
257
United Parcel Service
UPS
$88.7B
$13.6K ﹤0.01%
108
PFE icon
258
Pfizer
PFE
$152B
$13.4K ﹤0.01%
505
+106
+27% +$2.88K
PLD icon
259
Prologis
PLD
$133B
$13.3K ﹤0.01%
126
+17
+16% +$1.95K
GEV icon
260
GE Vernova
GEV
$269B
$13.2K ﹤0.01%
+40
New +$12.5K
BMRN icon
261
BioMarin Pharmaceuticals
BMRN
$13.4B
$13.1K ﹤0.01%
+200
New +$13.4K
FMS icon
262
Fresenius Medical Care
FMS
$12.7B
$12.6K ﹤0.01%
+556
New +$12.1K
MS icon
263
Morgan Stanley
MS
$339B
$12.6K ﹤0.01%
+100
New +$12.3K
TMO icon
264
Thermo Fisher Scientific
TMO
$223B
$12.5K ﹤0.01%
24
-25
-51% -$13.7K
NSP icon
265
Insperity
NSP
$1.94B
$12.4K ﹤0.01%
159
+44
+38% +$3.56K
SBUX icon
266
Starbucks
SBUX
$121B
$11.6K ﹤0.01%
127
+20
+19% +$1.94K
MDT icon
267
Medtronic
MDT
$115B
$11.6K ﹤0.01%
143
-68
-32% -$5.89K
BKR icon
268
Baker Hughes
BKR
$64.2B
$11.5K ﹤0.01%
280
+1
+0.4% +$40
NEE icon
269
NextEra Energy
NEE
$178B
$11K ﹤0.01%
154
+49
+47% +$3.81K
BSJP
270
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$11K ﹤0.01%
478
+8
+2% +$185
BSJQ icon
271
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$866M
$10.9K ﹤0.01%
469
+8
+2% +$187
MMM icon
272
3M
MMM
$94.4B
$10.7K ﹤0.01%
83
+1
+1% +$131
BSJR icon
273
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$882M
$10.7K ﹤0.01%
477
+9
+2% +$203
HPE icon
274
Hewlett Packard
HPE
$72B
$10.7K ﹤0.01%
+500
New +$10.6K
SNY icon
275
Sanofi
SNY
$104B
$10.6K ﹤0.01%
220
-690
-76% -$35.1K

Similar funds

CBIZ Investment Advisory Services's Q4 2024 Portfolio in Review

As of Q4 2024, CBIZ Investment Advisory Services held 517 positions worth $2B, up 4.1% from $1.93B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

CBIZ Investment Advisory Services deployed $112M of net new capital in Q4 2024, opening 113 new positions and adding to 216 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 7,194 shares worth $1.49M.

By sector, the portfolio is most concentrated in Industrials at 2% of assets, down from 2.3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $22M trimmed.

  • CBIZ Investment Advisory Services's largest Q4 2024 buy was iShares MSCI USA Momentum Factor ETF: 7,194 shares worth $1.49M.
  • CBIZ Investment Advisory Services added most to Vanguard Total Bond Market in Q4 2024, an estimated $80.8M increase.
  • CBIZ Investment Advisory Services's biggest Q4 2024 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $22M.
  • CBIZ Investment Advisory Services fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $492K.
  • CBIZ Investment Advisory Services's ten largest holdings make up 94% of its $2B portfolio in Q4 2024.
  • CBIZ Investment Advisory Services opened 113 new positions and closed 40 in Q4 2024.
  • CBIZ Investment Advisory Services's portfolio value rose 4.1% quarter-over-quarter to $2B.

Based on CBIZ Investment Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.